Zhende Medical Co Ltd (603301) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Zhende Medical Co Ltd (603301) has a cash flow conversion efficiency ratio of 0.017x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥101.93 Million ≈ $14.92 Million USD) by net assets (CN¥5.99 Billion ≈ $875.85 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Zhende Medical Co Ltd - Cash Flow Conversion Efficiency Trend (2014–2024)
This chart illustrates how Zhende Medical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 603301 total debt and obligations for a breakdown of total debt and financial obligations.
Zhende Medical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhende Medical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Camurus AB
ST:CAMX
|
0.060x |
|
Gitlab Inc
NASDAQ:GTLB
|
0.044x |
|
Tibet Huayu Mining Co Ltd
SHG:601020
|
0.047x |
|
Baytex Energy Corp
TO:BTE
|
0.095x |
|
Enova International Inc
NYSE:ENVA
|
0.373x |
|
ELF Beauty Inc
NYSE:ELF
|
0.051x |
|
PT Indofood Sukses Makmur Tbk
JK:INDF
|
0.076x |
|
Rubis SCA
PA:RUI
|
0.102x |
Annual Cash Flow Conversion Efficiency for Zhende Medical Co Ltd (2014–2024)
The table below shows the annual cash flow conversion efficiency of Zhende Medical Co Ltd from 2014 to 2024. For the full company profile with market capitalisation and key ratios, see Zhende Medical Co Ltd (603301) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥5.90 Billion ≈ $862.83 Million |
CN¥461.14 Million ≈ $67.48 Million |
0.078x | -3.05% |
| 2023-12-31 | CN¥5.60 Billion ≈ $820.10 Million |
CN¥452.11 Million ≈ $66.16 Million |
0.081x | -62.73% |
| 2022-12-31 | CN¥5.76 Billion ≈ $842.43 Million |
CN¥1.25 Billion ≈ $182.34 Million |
0.216x | +17.52% |
| 2021-12-31 | CN¥4.44 Billion ≈ $649.65 Million |
CN¥817.63 Million ≈ $119.64 Million |
0.184x | -73.64% |
| 2020-12-31 | CN¥4.47 Billion ≈ $653.65 Million |
CN¥3.12 Billion ≈ $456.68 Million |
0.699x | +394.48% |
| 2019-12-31 | CN¥1.40 Billion ≈ $204.82 Million |
CN¥197.76 Million ≈ $28.94 Million |
0.141x | +684.88% |
| 2018-12-31 | CN¥1.12 Billion ≈ $164.57 Million |
CN¥20.25 Million ≈ $2.96 Million |
0.018x | -94.47% |
| 2017-12-31 | CN¥560.19 Million ≈ $81.97 Million |
CN¥182.34 Million ≈ $26.68 Million |
0.326x | +2.93% |
| 2016-12-31 | CN¥438.18 Million ≈ $64.12 Million |
CN¥138.57 Million ≈ $20.28 Million |
0.316x | -41.84% |
| 2015-12-31 | CN¥262.45 Million ≈ $38.40 Million |
CN¥142.70 Million ≈ $20.88 Million |
0.544x | -31.23% |
| 2014-12-31 | CN¥105.77 Million ≈ $15.48 Million |
CN¥83.63 Million ≈ $12.24 Million |
0.791x | -- |
About Zhende Medical Co Ltd
Zhende Medical Co., Ltd. engages in the research and development, production, and sale of medical care and protective equipment in China and internationally. The company offers gauze swab, lap sponge, and fluff gauze swab; non-woven swab; PBT bandage, elastic bandage, crepe bandage, crochet bandage, selvedge bandage, under-cast padding, and fluff gauze roll; dressing set; first aid kit; cotton pa… Read more